594.27MMarket Cap-20.61P/E (TTM)
14.885High14.470Low607.60KVolume14.590Open14.470Pre Close8.90MTurnover1.88%Turnover RatioLossP/E (Static)40.62MShares66.54052wk High2.11P/B473.09MFloat Cap13.50052wk Low--Dividend TTM32.34MShs Float66.540Historical High--Div YieldTTM2.87%Amplitude8.800Historical Low14.643Avg Price1Lot Size
RxSight Stock Forum
RxSight Cuts 2025 Revenue Target by $25M Despite Strong Lens Sales Growth
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$